Search
for
Sort by
Research 91–120 of 1000+
- How to diagnose a lipodystrophy syndrome
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes
- Metabolic Aspects of Polycystic Ovary Syndrome
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- Type 2 Diabetic Mellitus Inhibits Skin Renewal through Inhibiting WNT-Dependent Lgr5+ Hair Follicle Stem Cell Activation in C57BL/6 Mice
- A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
- Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet
- Dermal‐Epidermal Cross‐Talk: Differential Interactions With Microvascular Endothelial Cells
- Topical application of synthetic melanin promotes tissue repair
- Pathophysiology of the burn scar
- β-Catenin–Dependent Wnt Signaling: A Pathway in Acute Cutaneous Wounding [RETRACTED]
- Hypersensitivity Reactions to Anticoagulant Drugs
- Honokiol protects skin cells against inflammation, collagenolysis, apoptosis, and senescence caused by cigarette smoke damage
- Current and future pharmacotherapy for alopecia areata
- Combination of an engineered <i>Lactococcus lactis</i> expressing CXCL12 with light‐emitting diode yellow light as a treatment for scalded skin in mice
- The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosis
- 033 IL-15 is an unexpected guardian of hair follicle immune privilege and promotes human hair growth ex vivo
- Diagnostic approach to low‐renin hypertension
- Indications for Peripheral and Central Sensitization in Patients With Chronic Scalp Pain (Trichodynia)
- Can gut flora changes be new biomarkers for depression?
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Genetic analysis of 5 α reductase type 2 enzyme in relation to oxidative stress in cases of androgenetic alopecia in a sample of egyptian population
- Androgenetic Alopecia in Polycystic Ovary Syndrome: A Cutaneous Marker of Systemic Metabo-inflammatory and Endocrine Dysfunction: A Narrative Review
- Prevalence and Predictors of Impaired Glucose Tolerance and Diabetes Mellitus Type 2 in Patients with Polycystic Ovary Syndrome
- 15460 Perifollicular pink halo: A potential dermoscopic marker of inflammation in central centrifugal cicatricial alopecia
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- Inflammatory and Anti-Inflammatory Parameters in PCOS Patients Depending on Body Mass Index: A Case-Control Study
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease